-+ 0.00%
-+ 0.00%
-+ 0.00%

QurieGen Partners With Rayca Precision to Develop Integrated Drug Discovery Workflow

PUBT·11/03/2026 19:54:57
Listen to the news
QurieGen Partners With Rayca Precision to Develop Integrated Drug Discovery Workflow
  • Lighthouse Ventures portfolio company QurieGen partnered with Rayca Precision to develop an integrated drug discovery workflow.
  • The workflow connects drug target discovery, AI-driven molecular design and experimental validation in a continuous feedback cycle.
  • QurieGen will test candidate molecules in disease-relevant cellular models, with results guiding subsequent molecular design.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lighthouse Ventures Gp sro published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.